These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15319592)

  • 1. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
    Kalinyak JE; McDougall IR
    Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
    [No Abstract]   [Full Text] [Related]  

  • 2. Do we read carefully?
    Medvedec M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid stunning revisited.
    Woolfenden JM
    J Nucl Med; 2006 Sep; 47(9):1403-5. PubMed ID: 16954545
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: the so-called stunning of thyroid tissue.
    Hilditch TE; Bolster AA; Dempsey MF; Reed NS
    J Nucl Med; 2007 Apr; 48(4):675-6; author reply 676. PubMed ID: 17401107
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
    Lees W; Mansberg R; Roberts J; Towson J; Chua E; Turtle J
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1421-7. PubMed ID: 12397458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid blocking policy--revisited.
    Solanki KK; Bomanji JB; Waddington WA; Ell PJ;
    Nucl Med Commun; 2004 Nov; 25(11):1071-6. PubMed ID: 15577583
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid stunning after (131)I diagnostic whole-body scanning.
    McMenemin RM; Hilditch TE; Dempsey MF; Reed NS
    J Nucl Med; 2001 Jun; 42(6):986-7. PubMed ID: 11390566
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid stunning in vivo and in vitro.
    Medvedec M
    Nucl Med Commun; 2005 Aug; 26(8):731-5. PubMed ID: 16000993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131.
    Sfakianakis G; Sfakianaki E
    Hell J Nucl Med; 2007; 10(1):2-5. PubMed ID: 17450241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of ionizing radiation on the thyroid].
    Gerasimov GA
    Probl Endokrinol (Mosk); 1991; 37(4):64-7. PubMed ID: 1788197
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent stunning and the impairment of successful ablation.
    Hu YH; Wang PW; Wang ST; Lee CH; Chen HY; Chou FF; Huang YE; Huang HH
    Nucl Med Commun; 2004 Aug; 25(8):793-7. PubMed ID: 15266173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 15. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
    Ma C; Xie J; Kuang A
    J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of toxicological hazards from medical radioiodine administration.
    Van Dyke M; Punja M; Hall MJ; Kazzi Z
    J Med Toxicol; 2015 Mar; 11(1):96-101. PubMed ID: 25008160
    [No Abstract]   [Full Text] [Related]  

  • 17. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 18. The so-called stunning of thyroid tissue.
    Sisson JC; Avram AM; Lawson SA; Gauger PG; Doherty GM
    J Nucl Med; 2006 Sep; 47(9):1406-12. PubMed ID: 16954546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
    Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
    J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stunning after tracer dosimetry.
    Diehl M; Grünwald F
    J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.